中国医药指南
中國醫藥指南
중국의약지남
CHINA MEDICINE GUIDE
2014年
17期
43-43,44
,共2页
癌痛%羟考酮%滴定
癌痛%羥攷酮%滴定
암통%간고동%적정
Cancer-pain%Oxycodone%Titration
目的:探讨盐酸羟考酮缓释片用于重度癌痛滴定的有效性及安全性。方法42例重度癌痛实体瘤患者,疼痛评分7~10分,盐酸羟考酮缓释片初始剂量20 mg起始滴定。根据患者疼痛情况及爆发痛治疗情况于12和24 h调整盐酸羟考酮缓释片(奥施康定)的剂量。结果42例重度癌痛患者中,1 h疼痛显著缓解率16.7%,12 h疼痛显著缓解率38.1%,24 h疼痛显著缓解率73.8%。不良反应以消化道症状为主。结论在重度癌痛中,盐酸羟考酮缓释片滴定具有快速、有效、安全及方便的优势。
目的:探討鹽痠羥攷酮緩釋片用于重度癌痛滴定的有效性及安全性。方法42例重度癌痛實體瘤患者,疼痛評分7~10分,鹽痠羥攷酮緩釋片初始劑量20 mg起始滴定。根據患者疼痛情況及爆髮痛治療情況于12和24 h調整鹽痠羥攷酮緩釋片(奧施康定)的劑量。結果42例重度癌痛患者中,1 h疼痛顯著緩解率16.7%,12 h疼痛顯著緩解率38.1%,24 h疼痛顯著緩解率73.8%。不良反應以消化道癥狀為主。結論在重度癌痛中,鹽痠羥攷酮緩釋片滴定具有快速、有效、安全及方便的優勢。
목적:탐토염산간고동완석편용우중도암통적정적유효성급안전성。방법42례중도암통실체류환자,동통평분7~10분,염산간고동완석편초시제량20 mg기시적정。근거환자동통정황급폭발통치료정황우12화24 h조정염산간고동완석편(오시강정)적제량。결과42례중도암통환자중,1 h동통현저완해솔16.7%,12 h동통현저완해솔38.1%,24 h동통현저완해솔73.8%。불량반응이소화도증상위주。결론재중도암통중,염산간고동완석편적정구유쾌속、유효、안전급방편적우세。
ObjectiveTo investigate the efifcacy and safety of chronic-release oxycodone to titrate moderate or severe cancer pain in opioid-naive patients with solid tumor.MethodPatients with solid tumor had pain score of 7 to 10, indicating severe pain, received oxycodone hydrochloride prolonged-release tablets with initial dose of 20 mg. Then oxycodone dosage was adjusted at 12 hour and 24 hour based on pain assessment.Result42 patients, signiifcant remission at 1 hour, 12 hour and 24 hour were 16.7%, 38.1% and 73.8%, respectively. The major adverse effect was gastrointestinal toxicities. ConclusionOxycodone hydrochloride prolonged-release tablets may have a rapid, effective, safe and convenient role in the titration treatment for severe cancer pain.